Optimizing patients’ outcomes: A comparative study of angiography and angioplasty procedures.
DOI:
https://doi.org/10.29309/TPMJ/2025.32.01.8398Keywords:
Angiography, Angioplasty, Coronary Artery Disease, Interventions, Outcomes, Percutaneous Coronary InterventionsAbstract
Objective: To compare angiography and angioplasty, assess how they affect patient outcomes, and pinpoint variables that could maximize each procedure. Study Design: Retrospective Cohort study. Setting: Afridi Medical Complex (AMC). Period: Jan. 2021 to Jan 2022. Methods: Comparing the outcomes of patients who underwent coronary angiography and those who underwent percutaneous coronary intervention (PCI), commonly referred to as angioplasty. Patients included adult patients aged 18 years and older who were diagnosed with CAD and underwent either coronary angiography or angioplasty procedures. Those with incomplete medical records, emergency revascularization, and concomitant procedures such as coronary artery bypass grafting (CABG) were excluded. Results: A total of 150 patients were included in this study, with a mean age of participants (57 ± 15.345), male predominance 67% compared to females 33%. Of the total population, 19.3% presented with dyslipidemia. Comparative analysis of angiography and percutaneous coronary intervention (PCI) procedures reveals notable differences in outcomes and complications. Cardiogenic shock was significantly more frequent in the PCI group 3.5% compared to the angiography group 2%, with a p-value of 0.04 indicating statistical significance. Conclusion: In conclusion, while angioplasty offers significant advantages in terms of symptom relief and functional outcomes, the role of angiography in diagnostic precision cannot be understated. Both procedures have distinct benefits and risks, and their use should be tailored to individual patient needs.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The Professional Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.